Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A thyroid hormone resistance syndrome characterized by resistance in the pituitary gland and in most or all of the peripheral tissues.
Biomarker and diagnostic research for generalized resistance to thyroid hormone has been reported in the published literature.
No clinical trials have been registered for generalized resistance to thyroid hormone.
145 publications have been identified in PubMed for generalized resistance to thyroid hormone. Research spans Review / Meta-Analysis (39%), Basic Science / Preclinical (26%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 56 | 39% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:51 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
37 |
26% |
Clinical study results | 24 | 17% |
Disease patterns and progression | 16 | 11% |
Patient case studies | 8 | 6% |
Testing and diagnosis research | 2 | 1% |
New treatment approaches | 2 | 1% |
Lal K (2026). [PMID: 41824887](https://pubmed.ncbi.nlm.nih.gov/41824887/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Zhang Y (2026). [PMID: 41176050](https://pubmed.ncbi.nlm.nih.gov/41176050/). *Clinica chimica acta; international journal of clinical chemistry*. [Basic Science / Preclinical]
Jena S (2026). [PMID: 41736347](https://pubmed.ncbi.nlm.nih.gov/41736347/). *JPMA. The Journal of the Pakistan Medical Association*. [Clinical Trial Publication]
Elechi JOG (2026). [PMID: 41554431](https://pubmed.ncbi.nlm.nih.gov/41554431/). *Mol Cell Endocrinol*. [Review / Meta-Analysis]
Wu YL (2026). [PMID: 40968430](https://pubmed.ncbi.nlm.nih.gov/40968430/). *Curr Diabetes Rev*. [Review / Meta-Analysis]
Yang J (2026). [PMID: 41649337](https://pubmed.ncbi.nlm.nih.gov/41649337/). *Archives of endocrinology and metabolism*. [Case Report / Case Series]
Moran C (2026). [PMID: 41131705](https://pubmed.ncbi.nlm.nih.gov/41131705/). *J Clin Endocrinol Metab*. [Clinical Trial Publication]
Iglesias P (2026). [PMID: 41912291](https://pubmed.ncbi.nlm.nih.gov/41912291/). *Vitam Horm*. [Review / Meta-Analysis]
Mahd Gharebagh F (2026). [PMID: 41519221](https://pubmed.ncbi.nlm.nih.gov/41519221/). *Clinica chimica acta; international journal of clinical chemistry*. [Diagnostic / Biomarker]
Zhang Y (2026). [PMID: 41238085](https://pubmed.ncbi.nlm.nih.gov/41238085/). *Biochimica et biophysica acta. Molecular basis of disease*. [Basic Science / Preclinical]